UBS O'Connor’s Abbott ABT Stock Holding History

UBS O'Connor’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,396	Closed	-$2.31M	–	324
2024 Q4	$2.31M	Sell	20,396 -8,326	-29%	-$962K	0.06%	142
2024 Q3	$3.27M	Buy	28,722 +19,722	+219%	+$2.16M	0.08%	126
2024 Q2	$935K	Buy	+9,000	New	+$954K	0.03%	306
2024 Q1	–	Sell	-5,769	Closed	-$635K	–	513
2023 Q4	$635K	Sell	5,769 -43,231	-88%	-$4.32M	0.02%	326
2023 Q3	$4.75M	Buy	+49,000	New	+$5.15M	0.08%	130

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS O'Connor's ABT Position: Q1 2025 in Review

UBS O'Connor sold out of Abbott (ABT) in Q1 2025, closing a stake of 20,396 shares — an estimated $2.31M sold.

UBS O'Connor first reported a position in ABT in Q3 2023 and held it in 5 quarters. The position peaked at $4.75M in Q3 2023. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

UBS O'Connor reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
UBS O'Connor sold 20,396 Abbott shares in Q1 2025, an estimated $2.31M.
UBS O'Connor first reported a position in Abbott in Q3 2023 and held it in 5 quarters.
UBS O'Connor's Abbott position peaked at $4.75M in Q3 2023.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.